J. Benavides

发表

Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation.

J. Bénavidès, X. Vigé, V. Zujovic, 2000, Glia.

Fractalkine modulates TNF‐α secretion and neurotoxicity induced by microglial activation

C. Carter, J. Bénavidès, X. Vigé, 2000 .

Increase in IL-6, IL-1 and TNF levels in rat brain following traumatic lesion Influence of pre- and post-traumatic treatment with Ro5 4864, a peripheral-type (p site) benzodiazepine ligand

J. Bénavidès, F. Zavala, S. Toulmond, 1993, Journal of Neuroimmunology.

Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons

D. Fage, J. Bénavidès, X. Vigé, 1992, Neuroscience Letters.

Mitotic-like Tau Phosphorylation by p25-Cdk5 Kinase Complex*

A. Delacourte, L. Buée, M. Hamdane, 2003, Journal of Biological Chemistry.

Progesterone synthesis and myelin formation in peripheral nerves

M. Schumacher, E. Baulieu, P. Lacor, 2001, Brain Research Reviews.

Regulation of the expression of peripheral benzodiazepine receptors and their endogenous ligands during rat sciatic nerve degeneration and regeneration: a role for PBR in neurosteroidogenesis

M. Schumacher, J. Bénavidès, P. Lacor, 1999, Brain Research.

Increased regional cerebral glucose uptake in an APP/PS1 model of Alzheimer's disease

M. Dhenain, B. Delatour, A. Volk, 2012, Neurobiology of Aging.

Effects of amisulpride, an atypical antipsychotic which blocks preferentially presynaptic dopamine autoreceptors, on integrated functional cerebral activity in the rat

D. Fage, B. Scatton, A. Cudennec, 1997, Brain Research.

SSR180575 (7-chloro-N,N,5-trimethyl-4-oxo-3-phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide), a peripheral benzodiazepine receptor ligand, promotes neuronal survival and repair.

P. Soubrié, M. Schumacher, Y. Claustre, 2002, The Journal of pharmacology and experimental therapeutics.

Recent developments in the behavioral pharmacology of benzodiazepine (ω) receptors: Evidence for the functional significance of receptor subtypes

G. Perrault, D. Sanger, C. Cohen, 1994, Neuroscience & Biobehavioral Reviews.

Experimental phenylketonuria: Metabolic studies in rat liver

J. Bénavidès, C. Giménez, F. Valdivieso, 1977, Molecular and Cellular Biochemistry.

Massive CA1/2 neuronal loss with intraneuronal and N-terminal truncated Abeta42 accumulation in a novel Alzheimer transgenic model.

T. Bayer, A. Delacourte, C. Schmitz, 2004, The American journal of pathology.

Transmembrane Domain III Plays an Important Role in Ion Binding and Permeation in the Glycine Transporter GLYT2*

B. Biton, P. Avenet, C. Aragón, 2000, The Journal of Biological Chemistry.

Heterologous Expression of Human α6β4β3α5 Nicotinic Acetylcholine Receptors: Binding Properties Consistent with Their Natural Expression Require Quaternary Subunit Assembly Including the α5 Subunit

R. Lukas, M. Bencherif, L. Pradier, 2005, Journal of Pharmacology and Experimental Therapeutics.

Heterologous expression of human {alpha}6{beta}4{beta}3{alpha}5 nicotinic acetylcholine receptors: binding properties consistent with their natural expression require quaternary subunit assembly including the {alpha}5 subunit.

R. Lukas, M. Bencherif, J. Bénavidès, 2005, Journal of Pharmacology and Experimental Therapeutics.

"Peripheral type" benzodiazepine binding sites in rat adrenals: binding studies with [3H]PK 11195 and autoradiographic localization.

J. Bénavidès, G. Le Fur, A. Uzan, 1983, Archives internationales de pharmacodynamie et de therapie.

Discriminative stimulus effects of ω (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system

D. Sanger, J. Benavides, 2005, Psychopharmacology.

2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—II Biochemical properties

J. Bénavidès, A. Uzan, C. Gueremy, 1985, Neuropharmacology.

Pharmacological heterogeneity of NMDA receptors in cerebellar granule cells in immature rat slices. A microfluorimetric study with the [Ca2+]i sensitive dye indo-1

M. Perrier, J. Benavides, 1995, Neuropharmacology.

Effect of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat brain

D. Duverger, B. Scatton, J. Nowicki, 1994, Brain Research.

Research report Effec(of eliprodil, an NMDA receptor antagonist acting at the polyamine modulatory site, on local cerebral glucose use in the rat brain

D. Duverger, B. Scatton, A. Cudennec, 1994 .

Prevention by eliprodil (SL 82.0715) of traumatic brain damage in the rat. Existence of a large (18h) therapeutic window

J. Bénavidès, B. Scatton, S. Toulmond, 1993, Brain Research.

The pharmacotherapy of focal cortical ischaemia in the mouse

E. Mackenzie, J. Bénavidès, B. Scatton, 1990, Brain Research.

Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.

E. Mackenzie, J. Vincent, P. Legendre, 1988, The Journal of pharmacology and experimental therapeutics.

Zolpidem and alpidem: two imidazopyridines with selectivity for omega 1- and omega 3-receptor subtypes.

J. Bénavidès, B. Scatton, S. Z. Langer, 1990, Advances in biochemical psychopharmacology.

Pharmacological characterization of in vivo [3H]lfenprodil binding sites in the mouse brain.

B. Scatton, J. Allen, B. Peny, 1992, The Journal of pharmacology and experimental therapeutics.

Therapeutic potential of the atypical non-competitive NMDA receptor antagonists, ifenprodil and SL 82.0715, in ischaemic cerebrovascular diseases

E. Mackenzie, B. Scatton, B. Gotti, 1990 .

An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over‐express a mutant form of human APP associated with Alzheimer's disease

J. Delgado-García, R. Sánchez-Campusano, V. Blanchard, 2004, The European journal of neuroscience.

Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse.

Santiago Canals, S. Canals, A. Brice, 2003, Human molecular genetics.

How Statins Could Be Evaluated Successfully in Clinical Trials for Alzheimer’s Disease?

J. Bénavidès, J. Burgos, F. Valdivieso, 2012, American journal of Alzheimer's disease and other dementias.

ABCA2 is a strong genetic risk factor for early-onset Alzheimer's disease

E. Génin, D. Campion, A. Brice, 2005, Neurobiology of Disease.

Facilitation of enkephalins catabolism inhibitor-induced antinociception by drugs classically used in pain management

B. Roques, J. Bénavidès, F. Noble, 2001, Neuropharmacology.

Comparative effects of FK-506, rapamycin and cyclosporin A, on the in vitro differentiation of dorsal root ganglia explants and septal cholinergic neurons

J. Bénavidès, X. Vigé, A. Carreau, 1997, Neuropharmacology.

Histidine modification with diethylpyrocarbonate induces a decrease in the binding of an antagonist, PK 11195, but not of an agonist, RO5-4864, of the peripheral benzodiazepine receptors.

J. Bénavidès, G. Le Fur, A. Uzan, 1984, Life sciences.

Potential Mechanisms Involved in the Negative Coupling Between Serotonin 5‐HT1A Receptors and Carbachol‐Stimulated Phosphoinositide Turnover in the Rat Hippocampus

Y. Claustre, J. Bénavidès, B. Scatton, 1991, Journal of neurochemistry.

Up‐regulation of genes involved in cellular stress and apoptosis in a rat model of hippocampal degeneration

S. Boularand, T. Smirnova, J. Nowicki, 2000, Journal of neuroscience research.

Unraveling substantia nigra sequential gene expression in a progressive MPTP-lesioned macaque model of Parkinson's disease

E. Bézard, C. Gross, J. Stutzmann, 2005, Neurobiology of Disease.

Enhanced expression of the peripheral benzodiazepine receptor (PBR) and its endogenous ligand octadecaneuropeptide (ODN) in the regenerating adult rat sciatic nerve

J. Bénavidès, P. Lacor, B. Ferzaz, 1996, Neuroscience Letters.

Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity.

K. Chergui, F. Gonon, H. Schoemaker, 1997, The Journal of pharmacology and experimental therapeutics.

In vivo interaction of zolpidem with central benzodiazepine (BZD) binding sites (as labeled by [3H]Ro 15-1788) in the mouse brain. Preferential affinity of zolpidem for the omega 1 (BZD1) subtype.

G. Perrault, B. Scatton, A. Dubois, 1988, The Journal of pharmacology and experimental therapeutics.

Synthesis of a [2-pyridinyl-18F]-labelled fluoro derivative of (-)-cytisine as a candidate radioligand for brain nicotinic alpha4beta2 receptor imaging with PET.

J. Bénavidès, F. Dollé, H. Valette, 2003, Bioorganic & medicinal chemistry.

Differentiation between two ligands for peripheral benzodiazepine binding sites, [3H]RO5-4864 and [3H]PK 11195, by thermodynamic studies.

J. Bénavidès, G. Le Fur, A. Uzan, 1983, Life sciences.

The quantification of brain lesions with anω 3 site ligand: a critical analysis of animal models of cerebral ischaemia and neurodegeneration

D. Duverger, E. Mackenzie, D. Fage, 1990, Brain Research.

Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage

C. Carter, D. Fage, J. Bénavidès, 1987, Brain Research.

In vivo labelling in several rat tissues of 'peripheral type' benzodiazepine binding sites.

J. Bénavidès, G. Fur, P. Rufat, 1984, European journal of pharmacology.

Labelling of “Peripheral‐Type” Benzodiazepine Binding Sites in the Rat Brain By Using [3H]PK 11195, an Isoquinoline Carboxamide Derivative: Kinetic Studies and Autoradiographic Localization

G. Fur, A. Uzan, C. Malgouris, 1983, Journal of neurochemistry.

Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission

M. Savasta, B. Scatton, A. Dubois, 1988, Neuroscience Letters.

Dual effects of thrombin and a 14-amino acid peptide agonist of the thrombin receptor on septal cholinergic neurons

J. Bénavidès, T. Debeir, X. Vigé, 1996, Brain Research.

Evidence for Differing Origins of the Serotonergic Innervation of Major Cerebral Arteries and Small Pial Vessels in the Rat

E. Mackenzie, G. Bonvento, D. Fage, 1991, Journal of neurochemistry.

Comparative autoradiographic distribution of central ω (benzodiazepine) modulatory site subtypes with high, intermediate and low affinity for zolpidem and alpidem

J. Bénavidès, B. Scatton, D. Ruano, 1993, Brain Research.

Regional differences in the enhancement by GABA of [3H]zolpidem binding to ω1 sites in rat brain membranes and sections

J. Bénavidès, D. Ruano, J. Vitorica, 1993, Brain Research.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide. I. In vitro studies.

G. Le Fur, A. Uzan, F. Imbault, 1983, Life sciences.

Effect of the putative 5-HT1A receptor antagonist NAN-190 on rat brain serotonergic transmission.

Y. Claustre, L. Rouquier, B. Scatton, 1991, European journal of pharmacology.

Activation of 5-HT1A receptors inhibits carbachol-stimulated inositol 1,4,5-trisphosphate mass accumulation in the rodent hippocampus

Y. Claustre, C. Minisclou, J. Benavides, 1995, Neurochemical Research.

Alpha 1-adrenoceptor antagonists differentially control serotonin release in the hippocampus and striatum: a microdialysis study.

Y. Claustre, L. Rouquier, J. Benavides, 1994, European journal of pharmacology.

5-HT1A receptor agonists inhibit carbachol-induced stimulation of phosphoinositide turnover in the rat hippocampus.

Y. Claustre, B. Scatton, J. Benavides, 1988, European journal of pharmacology.

Increase in ω3 (Peripheral-Type Benzodiazepine) binding site densities in different types of human brain tumours

P. Cornu, J. Bénavidès, B. Scatton, 1992, Acta Neurochirurgica.

Distribution of central omega 1 (benzodiazepine1) and omega 2 (benzodiazepine2) receptor subtypes in the monkey and human brain. An autoradiographic study with [3H]flunitrazepam and the omega 1 selective ligand [3H]zolpidem.

J. Bénavidès, B. Scatton, A. Dubois, 1988, The Journal of pharmacology and experimental therapeutics.

Comparative in vivo and in vitro regional selectivity of central omega (benzodiazepine) site ligands in inhibiting [3H]flumazenil binding in the rat central nervous system.

J. Bénavidès, B. Scatton, A. Durand, 1992, The Journal of pharmacology and experimental therapeutics.

Quantitative Autoradiography of [3H]Indalpine Binding Sites in the Rat Brain: I. Pharmacological Characterization

H. Savaki, G. Le Fur, A. Uzan, 1985, Journal of neurochemistry.

Comparative In vivo and In vitro Selectivity of Zolpidem for ω (Benzodiazepine) Modulatory Site Subtypes

J. Baron, J. Bénavidès, B. Scatton, 1995 .

Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice

Marc Dhenain, Philippe Hantraye, Thomas Debeir, 2012, Neurobiology of Aging.

Differential modulation of [3H]TCP binding to the NMDA receptor by L-glutamate and glycine.

C. Carter, B. Scatton, J. Rivy, 1988, European journal of pharmacology.

Increased neurosteroids synthesis after brain and spinal cord injury in rats

G. Bernardi, J. Bénavidès, A. Pasini, 2000, Neuroscience Letters.

Biochemical and histological alterations induced by fluid percussion brain injury in the rat

B. Scatton, B. Scatton, S. Toulmond, 1993, Brain Research.

Opposite effects of an agonist, RO5-4864, and an antagonist, PK 11195, of the peripheral type benzodiazepine binding sites on audiogenic seizures in DBA/2J mice.

G. Le Fur, A. Uzan, C. Renault, 1984, Life sciences.

Autoradiographic localization of peripheral benzodiazepine binding sites in the cat brain with [3H]PK 11195

M. Desban, J. Bénavidès, G. Fur, 1984, Brain Research Bulletin.

In vivo imaging of neuroinflammation in the rodent brain with [11C]SSR180575, a novel indoleacetamide radioligand of the translocator protein (18 kDa)

B. Tavitian, J. Bénavidès, N. Camp, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat

M. Savasta, B. Scatton, A. Dubois, 1986, Neuroscience Letters.

Transduction Mechanisms Involved in Thrombin Receptor‐Induced Nerve Growth Factor Secretion and Cell Division in Primary Cultures of Astrocytes

J. Bénavidès, T. Debeir, X. Vigé, 1996, Journal of neurochemistry.

Involvement of protease-activated receptor-1 in the in vitro development of mesencephalic dopaminergic neurons

J. Bénavidès, T. Debeir, X. Vigé, 1997, Neuroscience.

A risk for early-onset Alzheimer's disease associated with the APBB1 gene (FE65) intron 13 polymorphism

Jean-François Deleuze, Bruno Dubois, Didier Hannequin, 2003, Neuroscience Letters.

Stereoselective inhibition of the binding of [3H]PK 11195 to peripheral-type benzodiazepine binding sites by a quinolinepropanamide derivative.

A. Uzan, C. Renault, M. Dubroeucq, 1986, European journal of pharmacology.

Imaging of human brain lesions with an omega 3 site radioligand.

E. Mackenzie, P. Cornu, B. Scatton, 1988, Annals of neurology.

Imaging of primary and remote ischaemic and excitotoxic brain lesions. An autoradiographic study of peripheral type benzodiazepine binding sites in the rat and cat

D. Duverger, E. Mackenzie, D. Fage, 1988, Brain Research.

Characterization of solubilized "peripheral type" benzodiazepine binding sites from rat adrenals by using [3H]PK 11195, an isoquinoline carboxamide derivative.

G. Le Fur, A. Uzan, C. Renault, 1985, Biochemical pharmacology.

Dihydropyridine- and omega-conotoxin-resistant, neomycin-sensitive calcium channels mediate the depolarization-induced increase in internal calcium levels in cortical slices from immature rat brain.

B. Scatton, M. Perrier, J. Benavides, 1992, The Journal of pharmacology and experimental therapeutics.

Molecular and Pharmacological Characterization of Native Cortical γ-Aminobutyric AcidA Receptors Containing Both α1 and α3 Subunits*

H. Schoemaker, J. Bénavidès, D. Ruano, 1996, The Journal of Biological Chemistry.

Omega 3 (peripheral type benzodiazepine binding) site distribution in the rat immune system: an autoradiographic study with the photoaffinity ligand [3H]PK 14105.

E. Hamel, B. Scatton, A. Dubois, 1989, The Journal of pharmacology and experimental therapeutics.

Dihydropyridine and peripheral type benzodiazepine binding sites: subcellular distribution and molecular size determination.

J. Bénavidès, G. Le Fur, A. Uzan, 1985, European journal of pharmacology.

In vivo and in vitro interaction of the novel selective histamine H1 receptor antagonist mizolastine with H1 receptors in the rodent.

H. Schoemaker, Y. Claustre, J. Bénavidès, 1995, Arzneimittel-Forschung.

In vitro and in vivo characterization of TC‐1827, a novel brain α4β2 nicotinic receptor agonist with pro‐cognitive activity

M. Bencherif, G. Gatto, L. Pradier, 2004 .

PET study of carbon-11-PK 11195 binding to peripheral type benzodiazepine sites in glioblastoma: a case report.

C Crouzel, S. Pappatà, Y. Samson, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Aging‐Associated Changes in the Pharmacological Properties of the Benzodiazepine (ω) Receptor Isotypes in the Rat Hippocampus

D. Ruano, J. Vitorica, A. Machado, 1995, Journal of neurochemistry.

The imidazopyridine derivatives zolpidem and alpidem discriminate between central ω (benzodiazepine) receptor subtypes in rat brain sections

B. Scatton, B. Peny, J. Benavides, 1991, European Neuropsychopharmacology.

Pharmacological characterization of protease-activated receptor (PAR-1) in rat astrocytes.

J. Bénavidès, T. Debeir, X. Vigé, 1997, European journal of pharmacology.

L-glutamate increases internal free calcium levels in synaptoneurosomes from immature rat brain via quisqualate receptors

Y. Claustre, J. Bénavidès, B. Scatton, 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

SL 85.0324: a novel benzimidazole derivative with selective histamine H1-receptor antagonist properties

H. Schoemaker, Y. Claustre, B. Scatton, 1990 .

Imaging of human brain lesions with an ω3 site radioligand

Philippe Cornu, T. Dennis, E. Mackenzie, 1988 .

Pharmacological characterisation and autoradiographic distribution of polyamine-sensitive [3H]ifenprodil binding sites in the rat brain

H. Schoemaker, B. Scatton, C. Dana, 1991, Neuroscience Letters.

Circadian rhythm in the membrane of circulating human blood cells: microviscosity and number of benzodiazepine binding sites. A search for regulation by plasma ions, nucleosides, proteins or hormones.

J. Sulon, F. Lévi, Y. Touitou, 1987, Chronobiology international.

Biochemical evidence that 2-phenyl-4[2-(4-piperidinyl) ethyl]quinoline, a quinoline derivative with pure anticonflict properties, is a partial agonist of benzodiazepine receptors

G. Fur, A. Uzan, C. Malgouris, 1984, Neuropharmacology.

[Contribution of zolpidem in the management of sleep disorders].

G. Perrault, P. Robert, J. Lavoisy, 1992, L'Encephale.

Cellular distribution of ω 3 (peripheral type benzodiazepine) binding sites in the normal and ischaemic rat brain: An autoradiographic study with the photoaffinity ligand [3H]PK 14105

J. Bénavidès, B. Scatton, A. Dubois, 1990, Neuroscience Letters.

Peripheral Type Benzodiazepine Binding Sites as a Tool for the Detection and Quantification of CNS Injury

B. Scatton, A. Dubois, J. Benavides, 1999, Current protocols in neuroscience.

Increase inω3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-α and lipopolysaccharide

J. Bénavidès, B. Scatton, S. Toulmond, 1991, Brain Research.

Increase in omega 3 (peripheral type benzodiazepine) binding sites in the rat cortex and striatum after local injection of interleukin-1, tumour necrosis factor-alpha and lipopolysaccharide.

J. Bénavidès, B. Scatton, S. Toulmond, 1991, Brain research.

Biphasic transforming growth factor-β production flanking the pro-inflammatory cytokine response in cerebral trauma

F. Zavala, D. Lekieffre, A. Rimaniol, 1995, Neuroreport.

Peripheral benzodiazepine binding sites: effect of PK 11195, 1-(2-chlorophenyl)-N-methyl-(1-methylpropyl)-3 isoquinolinecarboxamide. II. In vivo studies.

J. Bénavidès, P. Rufat, G. Le Fur, 1983, Life sciences.

Serum levels of basic fibroblast growth factor in acute myocardial infarction.

J. Bénavidès, P. Cuevas, G. Giménez-Gallego, 1997, European journal of medical research.

Ifenprodil and Eliprodil: Neuroprotective NMDA Receptor Antagonists and Calcium Channel Blockers

G. Perrault, D. Sanger, H. Schoemaker, 1997 .

5-HT1C receptors mediate phosphoinositide turnover activation in the immature rat hippocampus.

Y. Claustre, B. Scatton, B. Eudeline, 1992, European journal of pharmacology.

Peripheral Type Benzodiazepine Binding Sites as a Tool for the Detection and Quantification of CNS Injury

B. Scatton, A. Dubois, J. Benavides, 1999, Current protocols in neuroscience.

Neuroprotection afforded by a combination of eliprodil and a thrombolytic agent, rt-PA, in a rat thromboembolic stroke model

J. Bénavidès, B. Scatton, D. Lekieffre, 1997, Brain Research.

Regional pattern of increased ω 3 (peripheral type benzodiazepine) binding site densities in the rat brain induced by systemic injection of kainic acid

J. Bénavidès, B. Scatton, A. Dubois, 1991, Neuroscience Letters.

Characterization of peripheral type benzodiazepine binding sites in human and rat platelets by using [3H]PK 11195. Studies in hypertensive patients.

G. Le Fur, A. Uzan, P. Plouin, 1984, Biochemical pharmacology.

The role of cytokines in neural pathology

B. Scatton, F. Bourdiol, J. Benavides, 1991, European Neuropsychopharmacology.

Radiosynthesis of 7-chloro-N,N-dimethyl-5-[11C]methyl-4-oxo-3- phenyl-3,5-dihydro-4H-pyridazino[4,5-b]indole-1-acetamide, [11C] SSR180575, a novel radioligand for imaging the TSPO (peripheral benzodiazepine receptor) with PET

R. Boisgard, B. Tavitian, F. Dollé, 2010 .